Mailing List

By joining the Alpha1-UK Mailing List you will be in contact with some 140 affected Alpha patients, and their families, living throughout the UK. We are a friendly group, and between us we have a wealth of knowledge and experience to share. There is always someone to help with any worries or queries you might have. If you would like to join us then please click here. Or, if you would like any further information then our Webmaster will be happy to help

Disclaimer

The information provided is for educational purposes only and is not intended nor implied to be a substitute for professional medical advice.
Always consult your own physician or healthcare provider with any questions you may have regarding a medical condition.

adapt logo true colour

What is ADAPT?

ADAPT (Antitrypsin Deficiency Assessment and Programme for Treatment) has been established by research doctors who have an international reputation for their research into the causes of emphysema, in collaboration with the pharmaceutical company Bayer.

ADAPT’s mission is to collect information about how AAT deficiency affects you and your family. As well as being helpful to you in understanding the effects of AAT deficiency on your lungs, this information will be critical to the design of clinical studies.

ADAPT News is an occasional booklet which gives information about the disease, research and treatment. Back copies are available from the ADAPT office, contact details below.

The Patient Community

Being a patient under ADAPT means that you meet other patients. There is an alpha-1 “community” in which patients support each other in friendship, sharing information, supporting research and so on.

Further information can be obtained:

Robert A. Stockley MD, D.Sc ., F.R.C.P.
Professor in Medicine

Mrs Rebecca Bray
Project Co-ordinator

Dr Anita Pye
Clinical Trials Co-ordinator

ADAPT Project
First Floor, Nuffield House
Queen Elizabeth Hospital
BIRMINGHAM
B15 2TH

Telephone: 0121-697-8257
Fax: 0121-697- 8256